Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving on BCG.

J L Stanford1

  • 1Department of Microbiology, School of Pathology, University College and Middlesex School of Medicine, London, U.K.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-Related Optical Characteristics of Thin Metallic Films in the Visible and Ultraviolet.

Journal of research of the National Bureau of Standards. Section A, Physics and chemistry·2020
Same author

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.

Prostate cancer and prostatic diseases·2018
Same author

Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.

Prostate cancer and prostatic diseases·2015
Same author

Replication of a genetic variant for prostate cancer-specific mortality.

Prostate cancer and prostatic diseases·2015
Same author

Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study.

Prostate cancer and prostatic diseases·2014
Same author

Genome-wide meta-analyses of smoking behaviors in African Americans.

Translational psychiatry·2012
Same journal

Immune Cell Composition and Prognosis in Node-Positive, Irradiated Breast Cancer Patients in the DBCG-IMN2 Study.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

Urinary Secretory-IgA and IgG Responses and Inflammatory Markers in Patients With Pseudomonas aeruginosa Urinary Tract Infections.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

Predictive Immunohistochemistry in Cholangiocarcinoma: Current Clinical Utility, Practical Limitations, and Emerging Directions.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

Active Chlorine Antiseptics in Wound Care: Recent Advances and Perspectives for Military Medicine.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

A Review on the Logistics, Financial, Ethical, and Regulatory Frameworks of Artificial Intelligence in Digital Pathology.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

UE, CT, and ACR TI-RADS Grading in the Combined Diagnosis of Benign and Malignant Thyroid Nodules.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
See all related articles

Bacille Calmette-Guérin (BCG) vaccination is crucial for tuberculosis and leprosy, but its effectiveness varies. Enhancing BCG with Mycobacterium vaccae shows promise for improving efficacy and immune response, especially in high-need regions.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Bacille Calmette-Guérin (BCG) is the primary vaccine for tuberculosis and leprosy.
  • BCG efficacy is suboptimal in developing regions where it's most needed.
  • Alternatives are distant; optimizing BCG use is critical.

Purpose of the Study:

  • To review BCG vaccine selection, administration timing, and potential enhancements.
  • To evaluate the efficacy of adding Mycobacterium vaccae to BCG.
  • To explore M. vaccae's role in modulating immune responses.

Main Methods:

  • Review of existing BCG preparations and efficacy data.
  • Analysis of factors influencing optimal BCG vaccination age.
  • Assessment of M. vaccae's impact on immune responses via skin tests.

Related Experiment Videos

Main Results:

  • BCG efficacy varies; selection should consider local factors.
  • Adding killed Mycobacterium vaccae to BCG may improve efficacy.
  • M. vaccae enhances recognition of common mycobacterial antigens.
  • M. vaccae may mitigate immunopathology in tuberculosis.
  • M. vaccae alone can boost immunity in BCG-unsuitable individuals.

Conclusions:

  • Optimizing BCG use requires careful selection and age-appropriate administration.
  • Mycobacterium vaccae shows potential as an adjuvant to enhance BCG efficacy and broaden immune responses.
  • M. vaccae offers a strategy to improve vaccination outcomes in diverse populations.